Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Dr. Rogerio Lilenbaum on Lung Cancer in the Elderly
Dr West
Here's the presentation by my friend and colleague Dr. Rogerio Lilenbaum, a great medical oncologist now serving as Director of Hematology/Oncology at the Cleveland Clinic Foundation in South Florida (Weston, FL). Though he's been renowned in lung cancer in general for many years, he's best known for his particular knowledge and leadership on the topic of managing lung cancer in elderly and frail (variably referred to as poor risk or poor performance status) patients.
Here is his talk, in audio and video podcast format, along with the associated figures and transcript:
[powerpress]
dr-lilenbaum-on-treating-lung-cancer-in-elderly-pts-audio-podcast
dr-lilenbaum-on-treating-lung-cancer-in-elderly-pts-figs
dr-lilenbaum-on-treating-lung-cancer-in-elderly-pts-transcript
His presentation includes a general perspective on principles of treating elderly patients and how we should be making recommendations, along with a summary of the evidence on chemotherapy for patients with resected early stage NSCLC, locally advanced NSCLC, and advanced/metastatic disease. It's a great overview of a big topic, and I hope it's very helpful.
We'll follow with a podcast of the live question and answer session that followed his presentation.
Thanks to LUNGevity Foundation for partnering with GRACE to develop this program.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Article
Imagine your body's defense system, the lymphatic system, suddenly turning against you. This is the reality for those facing lymphoma, a cancer of the immune system's crucial network. This article delves into the complexities of lymphoma, exploring its various forms, from the aggressive to the indolent, and examining the latest breakthroughs in treatment, including the groundbreaking POLARIX trial and cutting-edge therapies for relapsed cases. Whether you're a patient, a loved one, or simply curious about this complex disease, this comprehensive overview will provide valuable insights into the current state of lymphoma care and the promising future of research.
Image
Article
Registration is now open!
Join us for the annual 2024 Blood Cancers OncTalk!
Register Now!
Image
Video
Drs. Meredith McKean, Dr. Doug Micalizzi and patient advocate and lung cancer survivor, Ivy Elkins, discuss the importance of early detection and treatment across cancer types, including skin, lung, and breast.
To watch the complete playlist click here.
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...